Log on / register
Feedback | Support | My details
Open AccessHighly AccessStudy protocol

Study protocol: The Intensive Care Outcome Network ('ICON') study

John A Griffiths* email, Kayleigh Morgan* email, Vicki S Barber* email and J Duncan Young email

ICS Trials Group, Kadoorie Centre, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK

author email corresponding author email* Contributed equally

BMC Health Services Research 2008, 8:132doi:10.1186/1472-6963-8-132

Published: 17 June 2008

Abstract

Background

Extended follow-up of survivors of ICU treatment has shown many patients suffer long-term physical and psychological consequences that affect their health-related quality of life. The current lack of rigorous longitudinal studies means that the true prevalence of these physical and psychological problems remains undetermined.

Methods/Design

The ICON (Intensive Care Outcome Network) study is a multi-centre, longitudinal study of survivors of critical illness. Patients will be recruited prior to hospital discharge from 20–30 ICUs in the UK and will be assessed at 3, 6, and 12 months following ICU discharge for health-related quality of life as measured by the Short Form-36 (SF-36) and the EuroQoL (EQ-5D); anxiety and depression as measured by the Hospital Anxiety and Depression Scale (HADS); and post traumatic stress disorder (PTSD) symptoms as measured by the PTSD Civilian Checklist (PCL-C). Postal questionnaires will be used.

Discussion

The ICON study will create a valuable UK database detailing the prevalence of physical and psychological morbidity experienced by patients as they recover from critical illness. Knowledge of the prevalence of physical and psychological morbidity in ICU survivors is important because research to generate models of causality, prognosis and treatment effects is dependent on accurate determination of prevalence. The results will also inform economic modelling of the long-term burden of critical illness.

Trial Registration

ISRCTN69112866


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.